ArticleJournal of applied statistics2025
Estimating longitudinal biomarker effects using a Lasso-network constrained time-Varying mixed effects model.
Article in Journal of applied statistics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The relationship between covariates and outcomes can change over time, regardless of whether these covariates are time-varying or static. For instance, the influence of circulating biomarkers like white blood cell counts on the efficacy of standard chemotherapy in cancer patients may shift throughout the treatment duration. Traditional models with constant coefficients may fail to capture these dynamic interactions. Additionally, when multiple covariates are present, their interactions within and across time periods can become complex. To address these issues, we introduce a Lasso-Network constrained time-varying linear mixed-effects model (TVLMM) accompanied by an efficient two-stage parameter estimation algorithm that tracks the evolution of fixed-effect coefficients over time. We validate our approach through extensive simulations that highlight its effectiveness and computational efficiency in high-dimensional settings. Our method is further applied to real data from a randomized clinical trial of patients with metastatic colorectal cancer (mCRC), treated with standard chemotherapy with or without panitumumab. This case study demonstrates how our approach adeptly captures the time-varying impacts of critical circulating biomarkers on treatment outcomes, specifically tumor size reduction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.